Header Logo

Connection

Elisa Pabon to Hallucinogens

Back to Details
This is a "connection" page, showing publications Elisa Pabon has written about Hallucinogens.
Elisa Pabon
Connection Strength
2.153
Hallucinogens
  1. Impaired inhibition after delta-9-tetrahydrocannabinol in women not related to circulating estradiol levels. Pharmacol Biochem Behav. 2023 04; 225:173547.
    View in: PubMed
    Score: 0.822
  2. Controlled human drug administration studies are necessary to define the THC-sparing effects of CBD and other cannabis constituents. Neuropsychopharmacology. 2023 05; 48(6):850-851.
    View in: PubMed
    Score: 0.813
  3. Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women. Psychopharmacology (Berl). 2022 May; 239(5):1487-1497.
    View in: PubMed
    Score: 0.190
  4. ?9-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial. Neuropsychopharmacology. 2020 10; 45(11):1807-1816.
    View in: PubMed
    Score: 0.168
  5. Developing a phone-based measure of impairment after acute oral ?9-tetrahydrocannabinol. J Psychopharmacol. 2019 09; 33(9):1160-1169.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.